Related Experiment Video
Updated: Feb 10, 2026

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
SIV Latency in Macrophages in the CNS
Lucio Gama1, Celina Abreu1, Erin N Shirk1
1Department of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Abstract:
Lentiviruses infect myeloid cells, leading to acute infection followed by persistent/latent infections not cleared by the host immune system. HIV and SIV are lentiviruses that infect CD4+ lymphocytes in addition to myeloid cells in blood and tissues. HIV infection of myeloid cells in brain, lung, and heart causes tissue-specific diseases that are mostly observed during severe immunosuppression, when the number of circulating CD4+ T cells declines to exceeding low levels. Antiretroviral therapy (ART) controls viral replication but does not successfully eliminate latent virus, which leads to viral rebound once ART is interrupted. HIV latency in CD4+ lymphocytes is the main focus of research and concern when HIV eradication efforts are considered. However, myeloid cells in tissues are long-lived and have not been routinely examined as a potential reservoir. Based on a quantitative viral outgrowth assay (QVOA) designed to evaluate latently infected CD4+ lymphocytes, a similar protocol was developed for the assessment of latently infected myeloid cells in blood and tissues. Using an SIV ART model, it was demonstrated that myeloid cells in blood and brain harbor latent SIV that can be reactivated and produce infectious virus in vitro, demonstrating that myeloid cells have the potential to be an additional latent reservoir of HIV that should be considered during HIV eradication strategies.
Insights
Myeloid cells, not just CD4+ T cells, can harbor latent lentiviruses like HIV. This discovery suggests myeloid cells are a potential viral reservoir crucial for HIV eradication strategies.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Lentiviruses, including HIV and SIV, establish persistent infections by evading host immune responses.
- While HIV primarily targets CD4+ T cells, it also infects myeloid cells, contributing to tissue-specific diseases.
- Antiretroviral therapy (ART) suppresses viral replication but fails to eliminate latent virus, leading to viral rebound upon treatment interruption.
Purpose of the Study:
- To investigate the potential of myeloid cells as a latent reservoir for lentiviruses.
- To develop a method for assessing latent lentiviral infection in myeloid cells.
- To evaluate the role of myeloid cells in viral persistence and inform HIV eradication strategies.
Main Methods:
- Adaptation of the quantitative viral outgrowth assay (QVOA) for assessing latently infected myeloid cells.
- Application of the adapted QVOA in a SIV ART model using myeloid cells from blood and brain tissues.
- In vitro reactivation assays to determine the infectious potential of reactivated virus from myeloid reservoirs.
Main Results:
- Latent SIV was detected in myeloid cells from both blood and brain tissues in the SIV ART model.
- Reactivation of latent SIV from myeloid cells resulted in the production of infectious virus in vitro.
- These findings demonstrate that myeloid cells can harbor and release infectious lentiviruses.
Conclusions:
- Myeloid cells represent a significant, yet underappreciated, latent reservoir for lentiviruses.
- The presence of latent virus in myeloid cells has critical implications for HIV persistence and treatment failure.
- Considering myeloid cells as a viral reservoir is essential for developing effective HIV eradication strategies.
Related Concept Videos
Psychosexual Stages of Personality: Latency
The latency period is not...
CNS Depressants: Alcohol and Nicotine
CNS Depressants: Barbiturates and Benzodiazepines
CNS Stimulants: Psychedelic Agents
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
What is a Nervous System?

